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Narrative Questions
1. Describe how you came to choose your topic, specifically noting any
pre-research that you did. What sources did you use in this pre-research? To
what extent did you consult with librarians, faculty, or others? How did this
pre-research lead you to your topic?
I have always been a curious Biochemistry student who wants to work in the
pharmaceutical and healthcare-related fields. Therefore, I spend time exploring
discoveries in these fields to cultivate my knowledge and prepare myself as a Ph.D.
candidate after graduation. In several introductory biology courses, mutation-based
diseases appear to be one of the most complicated and almost-impossible-to treat
illnesses. Therefore, I shifted my attention from global infections to mutation
diseases due to genetic disorders. I was fortunate to be in the Intro to Biological
Inquiry class of Professor Martha Grossel, which prepared me with knowledge of
genetics. However, since I craved hands-on research in gene editing, this course
could not satisfy my needs. 2 years ago, I came across an article from Nature called
"Pioneers of revolutionary CRISPR gene editing win chemistry Nobel", which
presents the ground-breaking discovery by Emmanuelle Charpentier and Jennifer
Doudna on the CRISPR-Cas9 gene-editing system (Ledford and Callaway 2020,
346–47). The ability to replace damaged genes with healthy genes and correct
mutation was so fascinating that I could not stop reading. I talked to Professor
Deborah Eastman about my interest in researching the gene-editing mechanism, for
which there are three nucleases TALENs, CRISPR/Cas9, and ZFNs (Li et al. 2020,
1). She advised me to read some review articles to understand their pros and cons
before choosing the right one for me. Since the Nature article impressed me deeply,
it inspired me to do research in the CRISPR-Cas9 gene-editing system. However,
since this system has been used on a variety of animal models, including mouses,
rats, and even humans (Wu et al. 2013, 659–62), I struggled with finding my
research subject. I asked Professor Deborah Eastman for advice, and she
recommended I research the effect of CRISPR-Cas9 on the alteration of the lacZ
gene in Escherichia coli. I started by watching the "Gene Editing Mechanism of
CRISPR-Cas9" from the Wyss Institute of Harvard University, which gave the
visualization of how gene modification works. Then, I commenced my preliminary
research by reading several articles from Science Direct, PubMed, Scopus, etc,
which were recommended by Professor Sardha Suriyapperuma. Since this was
pre-research, I searched for articles using very general terms, such as "gene-editing
mechanism," "genome modification," "lacZ gene alteration," etc. She also advised
me to read more review articles on gene drive technology and DNA repair
mechanism to get the big picture of how my research can be. I also seek help from
the two passionate librarians, Andrew Lopez and Lori Looney, to help with my
pre-research. They provided me with tips on how to get the best out of One Search
and also introduced me to several scientific databases, including Academic One File
and PubMed Central. After doing the pre-research, I drew a brainstorming diagram
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to connect all the pieces and finalized my research. By reading different
experimental designs and confirming tests in several journal articles, I concluded
that I would evaluate the success of lacZ gene alteration based on the color of
colonies and perform PCR as well as gel electrophoresis to confirm my results.
References: Ledford, H., and E. Callaway. 2020. “Pioneers of Revolutionary CRISPR
Gene Editing Win Chemistry Nobel,” Nature 586, 586 (7829): 346–47.
https://doi.org/10.1038/d41586-020-02765-9. Li, Hongyi, Yang Yang, Weiqi Hong,
Mengyuan Huang, Min Wu, and Xia Zhao. 2020. "Applications of Genome Editing
Technology in the Targeted Therapy of Human Diseases: Mechanisms, Advances
and Prospects." Signal Transduction and Targeted Therapy 5 (1): 1.
https://doi.org/10.1038/s41392-019-0089-y. Wu, Yuxuan, Dan Liang, Yinghua Wang,
Meizhu Bai, Wei Tang, Shiming Bao, Zhiqiang Yan, Dangsheng Li, and Jinsong Li.
2013. "Correction of a Genetic Disease in Mouse Via use of CRISPR-Cas9." Cell
Stem Cell 13 (6): 659-662. https://doi.org/10.1016/j.stem.2013.10.016
2. Describe your process of finding information for your project. Note
specifically the tools you used to undertake your research, as well as the
specific search strategies you used within these tools. (Note: “Ebsco,” being
an umbrella vendor, is not a specific enough response when identifying tools;
listing the “library database” is also an unacceptably vague answer. Specific
tools include JSTOR, America: History & Life, Web of Science, etc., along with
OneSearch, the new library system.)
I was fortunate to attend a session on citations, bibliographies, and research
resources in Shain Library, where I was introduced to One Search, in my FYS-119K:
Virtual Realities in Japan. Besides searching for general key terms, such as "gene
drive technology," "genome-editing mechanisms" in One Search, Professor Deborah
Eastman recommended that I should use more specific terms if I want results closer
to my expectations. Therefore, I changed my strategy to searching using specific
terms such as "RNA-guided CRISPR-Cas9," "lacZ gene alteration," "DNA
breakage," to write a better background section. She also advised me to read review
articles, which provide a general understanding and cite the original articles as
evidence. This worked as a very effective resource for my research. After the
preliminary research, I narrowed down my reading to the CRISPR-Cas9 system and
the use of RNA and donor template DNA to design the experimental procedures.
Since I was new to research, I wanted to look for examples in reliable scientific
journal articles on PubMed and Science Direct to get an idea of the experimental
setup. This time, I focused heavily on the Materials and Methods section to start
designing the experiment. Since my subject was Escherichia coli, I tried to look for
experiments that were done on either Escherichia coli or Streptococcus Pyogenes (a
very similar species to E.coli) first. Once I obtained enough information on the
experimental methods and achieved certain results, I needed evidence from credible
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journals to back them up and cross-check. In this stage, I expanded my search to
other experimental designs as well to see if they still had the same results like mine
and referred to them in my Results and Discussion section. I also took advantage of
the helpful library service by visiting the Reference Desk. I asked librarian Andrew
Lopez for some advice on the databases I should use since using a credible
scientific database would ensure the reliability of the articles. He advised me to use
PubMed, Science Direct, and Nature, all of which contributed largely to my reference
sources. He also showed me how to select specific types of articles, such as
peer-reviewed articles and review articles, on PubMed and Science Direct. Librarian
Lori Looney showed me how to save all of the articles in Refworks and keep them in
a separate folder. I am very grateful for their help in my citations and bibliographies
as well since without them, I would not know about alphabetical rearrangements of
references and proper citation formats. In addition to that, I went to Professor
Sardha Suriyapperuma's office hours to seek more advice. She informed me that
PubMed Central provides free access to scientific articles, which helped me
substantially when finding the resources. I mainly used PubMed, PubMed Central,
Nature, and Science Direct since they not only offer reliable scientific articles, but
most of their journal articles are free and up-to-date.
3. Describe your process of evaluating the resources you found. How did you
make decisions about which resources you would use, and which you
wouldn’t? What kinds of questions did you ask yourself about resources in
order to determine whether they were worthy of inclusion?
After having read several journal articles, I was overwhelmed by loads of
information. Therefore, I calmed myself by writing an outline of what I planned to do
and compared it to what I found. There were times when the research I found
matched my interest, but it was done on another species (i.e humans) while I wanted
to research on CRISPR-Cas9 effect on Escherichia coli, which are substantially
different species. Therefore, the background and discussion sections of that article
were the only parts I looked at. Since Professor Deborah Eastman strongly required
journal articles that supported my results for cross-checking, I limited my findings
from CRISPR-Cas9 use in general to CRISPR-Cas9 use in Escherichia coli or
Streptococcus pyogenes (a similar species) and referred to their Materials and
Method and the Results and Discussion sections only. The DNA modification does
not only include the alteration of the lacZ gene but it also requires confirmation if the
gene changing was a success. Therefore, I focused on reading the Results and
Discussion section more to see the similarities and differences between my results
and theirs. I always ask myself: What do I want to prove to the scientific community?
What is my hypothesis? What evidence do I need to back it up? Since I
hypothesized that the lacZ gene could be successfully edited by CRISPR-Cas9
using sgRNA and HDR, I only read the journal articles that not only used the
CRISPR-Cas9 system but also utilized HDR instead of NHEJ to match with my
research. Using the term "Gene Drive Technology" when searching for journal and
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review articles might be too ambitious because of the four available nucleases used
for this mechanism, so I limited my reading to RNA-guided CRISPR-Cas9
mechanism only to save time. Since I already used credible resources from the
Shain Library, my professors, and well-known scientific databases, I did not have to
judge the credibility of the journals. Instead, I would evaluate their usefulness to my
research based on some criteria. How similar their experimental design is to my
procedure? It would be even better if they had a different experimental procedure
but still matched up with my results. Therefore, I would also look at papers that
researched the same topic but in different set-ups and achieved the same results as
I did as excellent evidence for my research paper. For example, according to Jiang
et al. (2013, 233–39), whose research subjects were Escherichia coli and
Streptococcus pyogenes, the CRISPR-Cas9 provided efficient gene editing using
crRNA and the donor template DNA. Even though they used a complex of
dual-RNA: Cas9, which is different from my complex of sgRNA: Cas9, my results
were still comparable to them in terms of the general concept. I also talked to
Professor Emily Tarsis and Professor Jacob Stewart on ways to find the most
effective resource. Their advice for me was that I can evaluate the usefulness of the
articles based on the abstract, which gives an overview of what the article was
about, and the Results and Discussion section, which provides the outcomes of the
research and the analysis. Thanks to these valuable resources, I am confident that I
can work on my honors thesis in my senior year and design my experimental
procedure.

CRISPR-CAS9 SYSTEM IN VITRO AND DNA MODIFICATIONS USING
HOMOLOGY-DIRECTED REPAIR MECHANISM
By Binh Vo
Abstract
The CRISPR-Cas9 system is one of the brightest candidates in genome editing in several species
(Wu et al. 2013, 659–62). The purpose of this study is to research the possibility of the lacZ gene
alteration using CRISPR-Cas9 in Escherichia coli and test the precision of the DNA modification.
It is possible to decide if the lacZ gene was altered based on the color of the colonies formed as a
result. However, to ensure the success of the DNA modification, multiplex PCR was used. The
yielded amplicons from the PCR test can be visualized using gel electrophoresis. The results
showed that the overall study was a success with some complications. The lacZ gene was
successfully edited in most samples with the donor template DNA; however, the study presented
some limitations during the procedure.

I.

Introduction

It has never been thought that humans can genetically engineer organisms and biological systems
to correct unwanted mutations. It was not until the first genetic modifications in mice and yeast in
the 1970s and 1980s that the scientific community started to believe in this incredible ability
(Carroll 2017, 653–59). This fascinating breakthrough opens the door for the gene-editing
mechanism and allows scientists to exceed the limitation of clinical interference on the human
body. Scientific advancement has never stopped growing, giving hopes to invent such gene
alteration technology that satisfies two criteria: simplicity and efficiency. The CRISPR-Cas9
system stands out as one of the best tools via the gene-editing mechanism (Xia et al. 2018, 699–

709) due to its high specificity and convenience. Recent studies show that the CRISPR-Cas9 can
correct unwanted mutations leading to severe diseases, such as sickle cell anemia (Demirci et al.
2019, 37–52) and cystic fibrosis (Marangi and Pistritto 2018, 396). There is also evidence of how
CRISPR-Cas9 contributes to the research of enhancing the efficacy of cancer therapeutic drugs
(Behan et al. 2019, 511+).

This study was conducted to test the practicality of the CRISPR-Cas9 system in vitro and observe
the DNA modifications. Generally, it can serve as one of the contributors to the knowledge of
CRISPR-Cas9 and its clinical applications. In this study, Escherichia coli utilized the CRISPRCas9 system to alter the lacZ gene, which is responsible for the coding of the enzyme βgalactosidase (β-gal). The lacZ gene is a constituent of the lac operon, a group of genes that enable
the bacteria to consume lactose. As a site for DNA insertion, the lacZ gene allows the bacterial
colony to have color as a result of the reaction between β-gal and X-gal (Juers, Matthews, and
Huber 2012, 1792–1807), signaling the completion of lacZ editing. This CRISPR-based method
involves Cas9 endonuclease, which cuts the genomic DNA at the targeted sites. The sgRNA
directed the CRISPR-associated Cas9 endonuclease to the desired DNA region recognized by the
protospacer-adjacent motif (PAM) sequence (Costa et al. 2004; Jiang et al. 2013, 233–39). After
the cut, the DNA suffers from a double-stranded break, which requires either homology-directed
repair (HDR) or nonhomologous end-joining (NHEJ) to repair (Ran et al. 2013, 2281–2308). It is
hypothesized that the lacZ gene can be successfully edited using the CRISPR-Cas9 system with
donor template DNA, sgRNA via the HDR mechanism.

II.

Materials and Methods

Bacterial Strain
In this study, the lacZ gene of Escherichia coli served as the target mutated by the CRISPR-Cas9
system. The bacterial strain utilized in the experiments was E. coli HB101-pBRKan, which
possesses a functional lacZ gene in its natural formation. For the purpose of this study, this strain
had undergone engineering modifications to express Cas9 and had had a plasmid containing
antibiotic-resistance genes. The plasmid served as a means for introducing sgRNA and donor
template DNA. For safety purposes, the bacteria were modified to disable the NHEJ performance.

Designing sgRNA and donor template DNA
The sgRNA includes a 20-nucleotide protospacer in the given lacZ gene followed by a PAM
sequence (5'-NGG, where N can be any nucleotide of interest). The protospacer was then pasted
to the tracer sequence to complete the sgRNA.

The donor template DNA had a length of 40 base pairs, including the deleted bases for a frameshift
mutation to the lacZ gene. Two homology arms of 15 base pairs, 5' and 3' homology arms, were
obtained to frame the lacZ sequence. The sequence for insertion was 10 base pairs long with
deleted bases.

Editing the lacZ gene with the sgRNA and the donor template DNA
The samples of this experiment obtained the colonies from the two starter plates, IPTG/X-gal and
IPTG/X-gal/ARA. Arabinose was added to activate the HDR mechanism and edit the lacZ gene.
Half of the samples had pLZDonorGuide plasmids, which provide the sgRNA and donor template
DNA for HDR mechanism activation and lacZ gene transformation. The other half received

pLZDonor plasmids, which only supplied the donor template DNA. The blue-white screening
technique was used to confirm the success of lacZ editing.

PCR test for confirming DNA modifications
The samples were tested using multiplex PCR to detect the presence of the target DNA sequence.
This test involves simultaneous amplification of several amplicons in one reaction utilizing a
unique primer set of each. Most of the PCR tubes obtained one blue colony each from either the
IX/ARA plate or the product samples of the previous stage. The remaining also received a white
colony each from the latter source. These PCR tubes became the materials for the PCR samples.

Besides the PCR samples receiving the supernatant from their compatible PCR tubes, the two PCR
controls were included in this test. The positive PCR control shows the standard of the PCR test
and yields amplicons. On the other hand, the negative PCR control can detect reagent
contamination or foreign DNA introduction to the samples. It will not yield any amplicons and
template or only have one or the other primer (forward/reverse primer).

Gel electrophoresis for visualizing the PCR products
Since each primer set yields a specific PCR amplicon, these amplicons of the PCR samples can be
separated using gel electrophoresis. The produced DNA bands on each PCR sample were
compared to the base pair ruler for the size and the PCR controls for the standard and
contamination detection.

III.

Results

The results from the lacZ gene transformation show that there was a mix of edited and unedited
lacZ genes. The modified lacZ gene produced white bacterial colonies, while its unmodified
counterpart yielded blue colonies. The amplicon amplification gave more insights in confirming if
the DNA was altered. In the multiplex PCR, the disruption of the primer binding sites or the
absence of the donor template DNA will inhibit the target PCR sequence from amplification. Each
PCR sample yielded specific amplicons by the primer sets. The produced 1,100 bp amplicon
signaled the failure of modifying the Cas9 cut site. The yielded 650 bp amplicon showed that the
target cut site was repaired using the donor DNA. PCR samples producing 350 bp amplicon were
determined to have the chromosomal DNA extracted and a successful PCR test. However, there
was no information on whether the lacZ gene was edited deduced from this amplicon. The gel
electrophoresis helped visualize the PCR products as DNA bands. The band of fluorescent dye
indicated that the PCR test was successful. The copied sequence of interest showed up as a single
DNA band. If there is more than the desired sequence, the gel will have more than a band.

1. Guide RNA and Donor template DNA design:
a) Single Guide RNA
A sgRNA directs the Cas9 endonuclease enzyme to the DNA of interest. Its guiding region is
designed to be complementary to the target DNA sequence, which signals to the Cas9 enzyme
the location of cutting sites.

DNA target:
5’tacaccaacg tgacctatcc cattacggtc aatccgccgt ttgttcccac ggagaatccg 3’
3’atgtggttgc actggatagg gtaatgccag ttaggcggca aacaagggtg cctcttaggc 5’

20-nucleotide protospacer:
3’gttgc actggatagg gtaat 5’
5’caacg tgacctatcc catta 3’
3’ guugc acuggauagg guaau 5’
5’caacg ugaccuaucc cauua 3’
The designed sgRNA:
5’caacg ugaccuaucc cauua3’5’GUUUUAGAGCUAGAAAUAGC
AAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGU
GCUUUUUU3’

b) Donor template DNA
Inserted sequence: tgcgcccatc
3’ |homology arm |
5’tacaccaacg tgacctatcc cattacggtc aatccgccgt ttgttcccac ggagaatccg 3’
5’ |homology arm|
3’atgtggttgc actggatagg gtaatgccag ttaggcggca aacaagggtg cctcttaggc 5’
5’ homology arm: ctatcc cattacggt
3’ homology arm: tacggtc aatccgcc
(The PAM sequence is colored in yellow, and the target sequence is colored in green.)
Donor template:
ctatcc cattacggt

Deleted base
tgcgcccatc tacggtc aatccgcc

5’homology arm inserted gene 3’homology arm

2. Plate Results

Figure 1
The above figure presents the visualization for the CRISPR samples A, B, C, and D. The small dots
on each plate are the bacterial colonies formed as a result of editing lacZ by using either plZDonor
or pLZDonorGuide plasmids for the HDR activation and DNA insertion.

Table 1. The summary of the results of the CRISPR plates in Figure 1
Plate

Bacteria
source

Plasmids

Cas9

HDR
system

sgRNA

Donor
Template
DNA

Predicted
lacZ change

Color of
colonies

Number of
colonies

A

IX

pLZDonor

+

OFF

-

+

Fail to be cut
by Cas9

Blue

160

B

IX

pLZDonorGuide

+

OFF

+

+

Can be cut
by Cas9

N/A

N/A

C

IX/ARA pLZDonor

+

ON

-

+

Fail to be cut
by Cas9

Blue

200

D

IX/ARA pLZDonorGuide

+

ON

+

+

Can be cut
by Cas9

White

220

Table 1
The above table gives detailed data yielded from the lacZ gene transformation. By using different plasmids,
sgRNA were supplied, and the HDR system was either activated or deactivated, resulting in a lacZ gene
change. The color and the number of bacterial colonies were reported to support the visualization shown in
Figure 1. If the lacZ gene was confirmed to be modified, the bacterial colonies yielded would have a blue
color; otherwise, it gave a white color.

3. PCR results:
Figure 2. The visulization of gel electrophoresis for the PCR products. The supporting figure
legends were arranged on the right of Figure 2.

Lane Sample
1

Molecular weight ruler (MWR)

2

Positive PCR control (+)

3

PCR sample S

4

PCR sample C

5

PCR sample D1

6

PCR sample D2

7

PCR sample D3

8

Negative PCR control (-)

Figure 2
All the PCR samples were put on an agarose gel to be tested by gel electrophoresis. Each PCR sample
yielded specific amplicons by the primer sets, which could provide the information about the DNA
insertion and the success of the PCR test. The bands on each lane represent the amplicons yielded by each
PCR sample. The far-left lane served as standard of size for the bands on the remaining lanes. The
specific data can be found in Table 2.

Table 2. The detailed data for Figure 2.
Amplicons
No.

PCR sample
1,100 bp

650 bp

1

MWR

✓

✓

2

Positive PCR control
(+)

✓

✓

3

PCR sample S

4

PCR sample C

5

PCR sample D1

6

PCR sample D2

7

PCR sample D3

8

Negative PCR
control (-)

350 bp

lacZ gene
status
Active

✓

Active

✓

✓

Active

✓

✓

Active

✓

✓

Inactive

✓

✓

Inactive

✓

N/A
Inactive

Table 2
The above table reports the specific amplicons that each PCR sample produced. From these data, the lacZ
gene status can be confirmed as either “active” or “inactive.” If there were no data or the amplicons expected
were not produced, the lacZ gene status would be reported as “N/A.”

IV.

Discussion and Conclusion

Generally, the findings of the study indicate that the CRISPR-Cas9 system allowed the editing in
the lacZ gene of Escherichia coli with the help of the donor template DNA and sgRNA via the
HDR mechanism (Deligianni and Kiamos 2021, 111415). Thus, the hypothesis of the study was
proved as correct since the use of sgRNA and donor template DNA via HDR mechanism showed
successful transformation in the lacZ gene and correct DNA insertion, which were confirmed by

the multiplex PCR and visualized by gel electrophoresis. The sgRNA and donor template DNA
presented as effective contributors to the gene-editing since the overall results showed that the lacZ
gene was edited successfully. In the plate results, most of the samples during the usage of sgRNA
and donor template DNA showed the expected color of colonies with one exception. This outlier
factor affected the data report of the number of colonies since it had no colonies observed. The
PCR results pointed out the limitation of the study as one of the PCR samples failed to yield the
expected amplicon and present the activity of the lacZ gene. All other PCR samples successfully
matched the predictions. The hypothesis could also be confirmed by the published result of Jiang
et al. (2013, 233–39). This study indicated that the CRISPR-Cas9 system requires the engineering
of crRNA (or sgRNA) and the donor template DNA to edit genes and, therefore, serves as a
powerful gene-editing tool.

There might have been contamination during the sample preparation or the overall procedure that
caused one of the plates to have no colonies shown. The unexpected result in the PCR visualization
may be due to human error - there is a possibility that the gel electrophoresis was not handled and
processed accurately. While these limitations did not heavily affect the overall outcome of this
study, it is crucial to acknowledge these errors and consider better laboratory techniques. The
samples could have been prepared better with sterile tools and appropriate reagents to prevent
contamination. Also, the handling of gel electrophoresis could have been done with cautious and
high precision for recording results.

The scientific community is constantly surprised with new technologies using the geneengineering mechanism. Recent works showed that these technologies are currently utilized in

high-throughput screening applications and present several potentials (Costa et al. 2004). Among
them, the CRISPR-Cas9 system has proved to be one of the most efficient gene-editing tools with
such simplicity and versatility. Researchers believe that it may have several advancements, which
expose its potential to the fullest.
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